[1]
|
Kim, B.Y.S., Rutka, J.T. and Chan, W.C.W. (2010) Nanomedicine. New England Journal of Medicine, 363, 2434-2443. http://dx.doi.org/10.1056/NEJMra0912273
|
[2]
|
Bharali, D.J. and Mousa, S.A. (2010) Emerging Nanomedicines for Early Cancer Detection and Improved Treatment: Current Perspective and Future Promise. Pharmacology & Therapeutics, 128, 324-335. http://dx.doi.org/10.1016/j.pharmthera.2010.07.007
|
[3]
|
Sajja, H.K., East, M.P., Mao, H., Wang, Y.A., Nie, S. and Yang, L. (2009) Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect. Current Drug Discovery Technologies, 6, 43-51. http://dx.doi.org/10.2174/157016309787581066
|
[4]
|
Ledet, G. and Mandal, T.K. (2012) Nanomedicine: Emerging Therapeutics for the 21st Century. U.S. Pharmacist, 37, 7-11.
|
[5]
|
Godin, B., Sakamoto, J.H., Serda, R.E., Grattoni, A., Bouamrani, A. and Ferrari, M. (2010) Emerging Applications of Nanomedicine for the Diagnosis and Treatment of Cardiovascular Diseases. Trends in Pharmacological Sciences, 31, 199-205. http://dx.doi.org/10.1016/j.tips.2010.01.003
|
[6]
|
Chhatriwalla, A.K. and Bhatt, D.L. (2008) Should Dual Anti-platelet Therapy after Drug-Eluting Stents Be Continued for More Than 1 Year? Circulation Cardiovascular Interventions, 1, 217-225. http://dx.doi.org/10.1161/CIRCINTERVENTIONS.108.811380
|
[7]
|
Galvin, P., Thompson, D., Ryan, K.B., McCarthy, A., Moore, A.C., Burke, C.S., et al. (2012) Nanoparticle-Based Drug Delivery: Case Studies for Cancer and Cardiovascular Applications. Cellular and Molecular Life Sciences, 69, 389-404. http://dx.doi.org/10.1007/s00018-011-0856-6
|
[8]
|
Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J.M., Grazú, V., et al. (2010) Multifunctional Nanocarriers for Diagnostics, Drug Delivery and Targeted Treatment Across Blood-Brain Barrier: Perspectives on Tracking and Neuroimaging. Particle and Fibre Toxicology, 7, 3. http://dx.doi.org/10.1186/1743-8977-7-3
|
[9]
|
World Health Organization (2011) Programmes and Projects: Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization, Geneva. http://www.who.int/cardiovascular_diseases/en/
|
[10]
|
Hoyert, D. and Xu, J. (2012) Deaths: Preliminary Data for 2011. National Vital Statistics Reports. National Center for Health Statistics, Hyattsville, 61, 1-65.
|
[11]
|
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M.J. (2009) Cancer Statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225-249. http://dx.doi.org/10.3322/caac.20006
|
[12]
|
Riehemann, K., Schneider, S.W., Luger, T.A., Godin, B., Ferrari, M. and Fuchs, H. (2009) Nanomedicine—Challenge and Perspectives. Angewandte Chemie International Edition, 48, 872-897. http://dx.doi.org/10.1002/anie.200802585
|
[13]
|
Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R. and Langer, R. (2007) Nanocarriers as an Emerging Platform for Cancer Therapy. Nature Nanotechnology, 2, 751-760. http://dx.doi.org/10.1038/nnano.2007.387
|
[14]
|
Ferrari, M. (2008) Nanogeometry: Beyond Drug Delivery. Nature Nanotechnology, 3, 131-132. http://dx.doi.org/10.1038/nnano.2008.46
|
[15]
|
Ferrari, M. (2005) Cancer Nanotechnology: Opportunities and Challenges. Nature Reviews Cancer, 5, 161-171. http://dx.doi.org/10.1038/nrc1566
|
[16]
|
Smith, R.C. and McCarthy, S. (1992) Physics of Magnetic Resonance. Journal of Reproductive Medicine, 37, 19-26.
|
[17]
|
Sosnovik, D.E., Nahrendorf, M. and Weissleder, R. (2008) Magnetic Nanoparticles for MR Imaging: Agents, Techniques and Cardiovascular Applications. Basic Research in Cardiology, 103, 122-130. http://dx.doi.org/10.1007/s00395-008-0710-7
|
[18]
|
Pan, D., Senpan, A., Caruthers, S.D., Williams, T.A., Scott, M.J., Gaffney, P.J., et al. (2009) Sensitive and Efficient Detection of Thrombus with Fibrin-Specific Manganese Nanocolloids. Chemical Communications, 3234-3236. http://dx.doi.org/10.1039/b902875g
|
[19]
|
Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., et al. (2005) Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics. Science, 307, 538-544. http://dx.doi.org/10.1126/science.1104274
|
[20]
|
Serda, R.E., Godin, B., Tasciotti, E., Liu, X. and Ferrari, M. (2009) Mitotic Trafficking of Silicon Microparticles. Nanoscale, 1, 250-259. http://dx.doi.org/10.1039/b9nr00138g
|
[21]
|
Kooi, M.E., Cappendijk, V.C., Cleutjens, K.B., Kessels, A.G., Kitslaar, P.J., Borgers, M., et al. (2003) Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by in Vivo Magnetic Resonance Imaging. Circulation, 107, 2453-2458. http://dx.doi.org/10.1161/01.CIR.0000068315.98705.CC
|
[22]
|
Devaraj, N.K., Keliher, E.J., Thurber, G.M., Nahrendorf, M. and Weissleder, R. (2009) 18F Labeled Nanoparticles for in Vivo PET-CT Imaging. Bioconjugate Chemistry, 20, 397-401. http://dx.doi.org/10.1021/bc8004649
|
[23]
|
Nahrendorf, M., Zhang, H., Hembrador, S., Panizzi, P., Sosnovik, D.E., Aikawa, E., et al. (2008) Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis. Circulation, 117, 379-387. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.741181
|
[24]
|
Chen, W., Vucic, E., Leupold, E., Mulder, W.J., Cormode, D.P., Briley-Saebo, K.C., et al. (2008) Incorporation of an apoE-Derived Lipopeptide in High-Density Lipoprotein MRI Contrast Agents for Enhanced Imaging of Macrophages in Atherosclerosis. Contrast Media & Molecular Imaging, 3, 233-242. http://dx.doi.org/10.1002/cmmi.257
|
[25]
|
Amirbekian, V., Lipinski, M.J., Briley-Saebo, K.C., Amirbekian, S., Aguinaldo, J.G., Weinreb, D.B., et al. (2007) Detecting and Assessing Macrophages in Vivo to Evaluate Atherosclerosis Noninvasively Using Molecular MRI. Proceedings of the National Academy of Sciences of the United States of America, 104, 961-966. http://dx.doi.org/10.1073/pnas.0606281104
|
[26]
|
Cyrus, T., Abendschein, D.R., Caruthers, S.D., Harris, T.D., Glattauer, V., Werkmeister, J.A., et al. (2006) MR Three-Dimensional Molecular Imaging of Intramural Biomarkers with Targeted Nanoparticles. Journal of Cardiovascular Magnetic Resonance, 8, 535-541. http://dx.doi.org/10.1080/10976640600580296
|
[27]
|
Botnar, R.M., Buecker, A., Wiethoff, A.J., Parsons Jr., E.C., Katoh, M., Katsimaglis, G., et al. (2004) In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent. Circulation, 110, 1463-1466. http://dx.doi.org/10.1161/01.CIR.0000134960.31304.87
|
[28]
|
Lanza, G.M., Trousil, R.L., Wallace, K.D., Rose, J.H., Hall, C.S., Scott, M.J., et al. (1998) In Vitro Characterization of a Novel, Tissue-Targeted Ultrasonic Contrast System with Acoustic Microscopy. The Journal of the Acoustical Society of America, 104, 3665-3672. http://dx.doi.org/10.1121/1.423948
|
[29]
|
Morawski, A.M., Winter, P.M., Crowder, K.C., Caruthers, S.D., Fuhrhop, R.W., Scott, M.J., et al. (2004) Targeted Nanoparticles for Quantitative Imaging of Sparse Molecular Epitopes with MRI. Magnetic Resonance in Medicine, 51, 480-486. http://dx.doi.org/10.1002/mrm.20010
|
[30]
|
Winter, P.M., Morawski, A.M., Caruthers, S.D., Fuhrhop, R.W., Zhang, H., Williams, T.A., et al. (2003) Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis with Alpha(v) Beta3-Integrin-Targeted Nanoparticles. Circulation, 108, 2270-2274. http://dx.doi.org/10.1161/01.CIR.0000093185.16083.95
|
[31]
|
Kao, C.Y., Hoffman, E.A., Beck, K.C., Bellamkonda, R.V. and Annapragada, A.V. (2003) Long-Residence-Time Nano-Scale Liposomal Iohexol for X-Ray-Based Blood Pool Imaging. Academic Radiology, 10, 475-483. http://dx.doi.org/10.1016/S1076-6332(03)80055-7
|
[32]
|
Mukundan Jr., S., Ghaghada, K.B., Badea, C.T., Kao, C.Y., Hedlund, L.W., Provenzale, J.M., et al. (2006) A Liposomal Nanoscale Contrast Agent for Preclinical CT in Mice. American Journal of Roentgenology, 186, 300-307. http://dx.doi.org/10.2214/AJR.05.0523
|
[33]
|
Christodoulides, N., Dharshan, P., Wong, J., Floriano, P.F., Neikirk, D. and McDevitt, J.T. (2007) A Microchip-Based Assay for Interleukin-6. Methods in Molecular Biology, 385, 131-144. http://dx.doi.org/10.1007/978-1-59745-426-1_10
|
[34]
|
Goodey, A., Lavigne, J.J., Savoy, S.M., Rodriquez, M.D., Curey, T., Tsao, A., et al. (2001) Development of Multianalyte Sensor Arrays Composed of Chemically Derivitized Polymeric Microspheres Localized in Micromachined Cavities. Journal of the American Chemical Society, 123, 2559-2570. http://dx.doi.org/10.1021/ja003341l
|
[35]
|
Christodoulides, N., Tran, M., Floriano, P.N., Rodriquez, M., Goodey, A., Ali, M., et al. (2002) A Microchip-Based Multianalyte Assay System for the Assessment of Cardiac Risk. Analytical Chemistry, 74, 3030-3036. http://dx.doi.org/10.1021/ac011150a
|
[36]
|
Ali, M.F., Kirby, R., Goodey, A.P., Rodriguez, M.D., Ellington, A.D., Neikirk, D.P., et al. (2003) DNA Hybridization and Discrimination of Singlenucleotide Mismatches Using Chip-Based Microbead Arrays. Analytical Chemistry, 75, 4732-4739. http://dx.doi.org/10.1021/ac034106z
|
[37]
|
Jokerst, J.V., Raamanathan, A., Christodoulides, N., Floriano, P.N., Pollard, A.A., Simmons, G.W., et al. (2009) Nano-Bio-Chips for High Performance Multiplexed Protein Detection: Determinations of Cancer Biomarkers in Serum and Saliva Using Quantum Dot Bioconjugate Labels. Biosensors and Bioelectronics, 24, 3622-3629. http://dx.doi.org/10.1016/j.bios.2009.05.026
|
[38]
|
Lavigne, J.J., Savoy, S., Clevenger, M.B., Ritchie, J.E., McDoniel, B., Yoo, S.J., et al. (1998) Solution-Based Analysis of Multiple Analytes by a Sensor Array: Toward the Development of an “Electronic Tongue”. Journal of the American Chemical Society, 120, 6429-6430. http://dx.doi.org/10.1021/ja9743405
|
[39]
|
Christodoulides, N., Floriano, P.N., Mohanty, S., Dharshan, P., Griffin, M., Lennart, A., et al. (2007) Lab-on-a-Chip Methods for Point of Care Measurements of Salivary Bio-markers of Periodontitis. Annals of the New York Academy of Sciences, 1098, 411-428. http://dx.doi.org/10.1196/annals.1384.035
|
[40]
|
Christodoulides, N., Mohanty, S., Miller, C.S., Langub, M.C., Floriano, P.N., Dharshan, P., et al. (2005) Application of Microchip Assay System for the Measurement of C-Reactive Protein in Human Saliva. Lab on a Chip, 5, 261-269. http://dx.doi.org/10.1039/b414194f
|
[41]
|
Christodoulides, N., Floriano, P.N., Sanchez, X., Li, L.Y., Hocquard, K., Patton, A., et al. (2012) Programmable Bio-Nanochip Technology for the Diagnosis of Cardiovascular Disease at the Point of Care. Methodist Debakey Cardiovascular Journal, 8, 6-12. http://dx.doi.org/10.14797/mdcj-8-1-6
|
[42]
|
Floriano, P.N., Christodoulides, N., Miller, C.S., Ebersole, J.L., Spertus, J., Rose, B.G., et al. (2009) Use of Saliva-Based Nano-Biochip Tests for Acute Myocardial Infarction at the Point of Care: A Feasibility Study. Clinical Chemistry, 55, 1530-1538. http://dx.doi.org/10.1373/clinchem.2008.117713
|
[43]
|
Vasan, R.S. (2006) Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations. Circulation, 113, 2335-2362. http://dx.doi.org/10.1161/CIRCULATIONAHA.104.482570
|
[44]
|
Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D., Collins, R., Kostis, J.B., et al. (2005) Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-Analysis. JAMA, 294, 1799-1809.
|
[45]
|
Cushman, M., Lemaitre, R.N., Kuller, L.H., Psaty, B.M., Macy, E.M., Sharrett, A.R., et al. (1999) Fibrinolytic Activation Markers Predict Myocardial Infarction in the Elderly. The Cardiovascular Health Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 493-498. http://dx.doi.org/10.1161/01.ATV.19.3.493
|
[46]
|
Wang, T.J., Larson, M.G., Levy, D., Benjamin, E.J., Leip, E.P., Omland, T., et al. (2004) Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death. New England Journal of Medicine, 350, 655-663. http://dx.doi.org/10.1056/NEJMoa031994
|
[47]
|
Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., et al. (2004) C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease. New England Journal of Medicine, 350, 1387-1397. http://dx.doi.org/10.1056/NEJMoa032804
|
[48]
|
Mangoni, A.A. and Jackson, S.H. (2002) Homocysteine and Cardiovascular Disease: Current Evidence and Future Prospects. The American Journal of Medicine, 112, 556-565. http://dx.doi.org/10.1016/S0002-9343(02)01021-5
|
[49]
|
Gaspari, M., Cheng, M., Terracciano, R., Liu, X., Nijdam, A.J., Vaccari, L., et al. (2006) Nanoporous Surfaces as Harvesting Agents for Mass Spectrometric Analysis of Peptides in Human Plasma. Journal of Proteome Research, 5, 1261-1266. http://dx.doi.org/10.1021/pr050417+
|
[50]
|
Luchini, A., Geho, D.H., Bishop, B., Tran, D., Xia, C., Dufour, R.L., et al. (2008) Smart Hydrogel Particles: Biomarker Harvesting: One-Step Affinity Purification, Size Exclusion, and Protection against Degradation. Nano Letters, 8, 350-361. http://dx.doi.org/10.1021/nl072174l
|
[51]
|
Cui, Y., Wei, Q., Park, H. and Lieber, C.M. (2001) Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species. Science, 293, 1289-1292. http://dx.doi.org/10.1126/science.1062711
|
[52]
|
Yang, Z. and Zhou, D.M. (2006) Cardiac Markers and Their Point-of-Care Testing for Diagnosis of Acute Myocardial Infarction. Clinical Biochemistry, 39, 771-780. http://dx.doi.org/10.1016/j.clinbiochem.2006.05.011
|
[53]
|
Brogan Jr., G.X. and Bock, J.L. (1998) Cardiac Marker Point-of-Care Testing in the Emergency Department and Cardiac Care Unit. Clinical Chemistry, 44, 1865-1869.
|
[54]
|
Park, J.S., Cho, M.K., Lee, E.J., Ahn, K.Y., Lee, K.E., Jung, J.H., et al. (2009) A Highly Sensitive and Selective Diagnostic Assay Based on Virus Nanoparticles. Nature Nanotechnology, 4, 259-264. http://dx.doi.org/10.1038/nnano.2009.38
|
[55]
|
Vogt, S., Troitzsch, D., Späth, S. and Moosdorf, R. (2004) Efficacy of Ion-Selective Probes in Early Epicardial in Vivo Detection of Myocardial Ischemia. Physiological Measurement, 25, N21-N26. http://dx.doi.org/10.1088/0967-3334/25/6/N02
|
[56]
|
Ji, T., Rai, P., Jung, S. and Varadan, V.K. (2008) In Vitro Evaluation of Flexible pH and Potassium Ion-Sensitive Organic Field Effect Transistor Sensors. Applied Physics Letters, 92, Article ID: 233304. http://dx.doi.org/10.1063/1.2936296
|
[57]
|
Barhoumi, H., Haddad, R., Maaref, A., Bausells, J., Bessueille, F., Léonard, D., et al. (2001) New Technology for Multi-Sensor Silicon Needles for Biomedical Applications. Sensors and Actuators B: Chemical, 78, 279-284. http://dx.doi.org/10.1016/S0925-4005(01)00826-7
|
[58]
|
Shin, K.H., Moon, C.R., Lee, T.H., Lim, C.H. and Kim, Y.J. (2005) Flexible Wireless Pressure Sensor Module. Sensors and Actuators A, 123-124, 30-35. http://dx.doi.org/10.1016/j.sna.2005.01.008
|
[59]
|
Kim, J.-H., Heller, D.A., Jin, H., Barone, P.W., Song, C., Zhang, J.Q., et al. (2009) The Rational Design of Nitric Oxide Selectivity in Single-Walled Carbon Nanotube Nearinfrared Fluorescence Sensors for Biological Detection. Nature Chemistry, 1, 473-481. http://dx.doi.org/10.1038/nchem.332
|
[60]
|
Lammers, T., Kiessling, F., Hennink, W.E. and Storm, G. (2010) Nanotheranostics and Image-Guided Drug Delivery: Current Concepts and Future Directions. Molecular Pharmaceutics, 7, 1899-1912. http://dx.doi.org/10.1021/mp100228v
|
[61]
|
Barenholz, Y. (2012) Doxil®—The First FDA-Approved Nano-Drug: Lessons Learned. Journal of Controlled Release, 160, 117-134. http://dx.doi.org/10.1016/j.jconrel.2012.03.020
|
[62]
|
Mufamadi, M.S., Pillay, V., Choonara, Y.E., Du Toit, L.C., Modi, G. and Naidoo, D. (2011) A Review on Composite Liposomal Technologies for Specialized Drug Delivery. Journal of Drug Delivery, 2011, Article ID: 939851. http://dx.doi.org/10.1155/2011/939851
|
[63]
|
Maurer, N., Fenske, D.B. and Cullis, P.R. (2001) Developments in Liposomal Drug Delivery Systems. Expert Opinion on Biological Therapy, 1, 923-947. http://dx.doi.org/10.1517/14712598.1.6.923
|
[64]
|
Immordino, M.L., Dosio, F. and Cattel, L. (2006) Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential. International Journal of Nanomedicine, 1, 297-315.
|
[65]
|
Hedman, M., Hartikainen, J. and Syvanne, M. (2003) Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT). Circulation, 107, 2677-2683. http://dx.doi.org/10.1161/01.CIR.0000070540.80780.92
|
[66]
|
Margolis, J., McDonald, J., Heuser, R., Klinke, P., Waksman, R., Virmani, R., et al. (2007) Systemic Nanoparticle Paclitaxel (Nab-Paclitaxel) for In-Stent Restenosis I (SNAPIST-I): A First-in-Human Safety and Dose-Finding Study. Clinical Cardiology, 30, 165-170. http://dx.doi.org/10.1002/clc.20066
|
[67]
|
McDowell, G., Slevin, M. and Krupinski, J. (2011) Nanotechnology for the Treatment of Coronary in Stent Restenosis: A Clinical Perspective. Vascular Cell, 3, 8. http://dx.doi.org/10.1186/2045-824X-3-8
|
[68]
|
Zhang, H., Li, N. and Sirish, P. (2012) The Cargo of CRPPR-Conjugated Liposomes Crosses the Intact Murine Cardiac Endothelium. Journal of Controlled Release, 163, 10-17. http://dx.doi.org/10.1016/j.jconrel.2012.06.038
|
[69]
|
Harel-Adar, T., Ben Mordechai, T., Amsalem, Y., Feinberg, M.S., Leor, J. and Cohen, S. (2011) Modulation of Cardiac Macrophages by Phosphatidylserine-Presenting Liposomes Improves Infarct Repair. Proceedings of the National Academy of Sciences of the United States of America, 108, 1827-1832. http://dx.doi.org/10.1073/pnas.1015623108
|
[70]
|
Dvir, T., Bauer, M., Schroeder, A., Tsui, J.H., Anderson, D.G., Langer, R., et al. (2011) Nanoparticles Targeting the Infarcted Heart. Nano Letters, 11, 4411-4444. http://dx.doi.org/10.1021/nl2025882
|
[71]
|
Lestini, B.J., Sagnella, S.M., Xu, Z., Shive, M.S., Richter, N.J., Jayaseharan, J., et al. (2002) Surface Modification of Liposomes for Selective Cell Targeting in Cardiovascular Drug Delivery. Journal of Controlled Release, 78, 235-247. http://dx.doi.org/10.1016/S0168-3659(01)00505-3
|
[72]
|
Holland, N.B., Qiu, Y., Ruegsegger, M. and Marchant, R.E. (1998) Biomimetic Engineering of Non-Adhesive Glycocalyx-Like Surfaces Using Oligosaccharide Surfactant Polymers. Nature, 392, 799-801. http://dx.doi.org/10.1038/33894
|
[73]
|
Zhu, J., Xue, J., Guo, Z., Zhang, L. and Marchant, R.E. (2007) Biomimetic Glycoliposomes as Nanocarriers for Targeting P-Selectin on Activated Platelets. Bioconjugate Chemistry, 18, 1366-1369. http://dx.doi.org/10.1021/bc700212b
|
[74]
|
Joner, M., Morimoto, K., Kasukawa, H., Steigarwald, K., Meri, S., Nakazawa, G., et al. (2008) Site-Specific Targeting of Nanoparticle Prednisolone Reduces In-Stent Restenosis in a Rabbit Model of Established Atheroma. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1960-1966. http://dx.doi.org/10.1161/ATVBAHA.108.170662
|
[75]
|
Cho, B.H., Park, J.R., Nakamura, M.T., Odintsov, B.M., Wallig, M.A. and Chung, B.H. (2010) Synthetic Dimyristoylphosphatidylcholine Liposomes Assimilating into High-Density Lipoprotein Promote Regression of Atherosclerotic Lesions in Cholesterol-Fed Rabbits. Experimental Biology and Medicine, 235, 1194-1203. http://dx.doi.org/10.1258/ebm.2010.009320
|
[76]
|
Walton, B.L., Leja, M., Vickers, K.C., Estevez-Fernandez, M., Sanguino, A., Wang, E., et al. (2010) Delivery of Negatively Charged Liposomes into the Atheromas of Watanabe Heritable Hyperlipidemic Rabbits. Vascular Medicine, 15, 307-313. http://dx.doi.org/10.1177/1358863X10374118
|
[77]
|
Danenberg, H.D., Fishbein, I., Gao, J., Mönkkönen, J., Reich, R., Gati, I., et al. (2002) Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation after Balloon Injury in Rats and Rabbits. Circulation, 106, 599-605. http://dx.doi.org/10.1161/01.CIR.0000023532.98469.48
|
[78]
|
Buxton, D.B. (2009) Nanomedicine for the Management of Lung and Blood Diseases. Nanomedicine, 4, 331-339. http://dx.doi.org/10.2217/nnm.09.8
|
[79]
|
Cyrus, T., Zhang, H., Allen, J.S., Williams, T.A., Hu, G., Caruthers, S.D., et al. (2008) Intramural Delivery of Rapamycin with Alphavbeta3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis after Balloon Injury. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 820-826. http://dx.doi.org/10.1161/ATVBAHA.107.156281
|
[80]
|
Winter, P.M., Caruthers, S.D., Zhang, H., Williams, T.A., Wickline, S.A. and Lanza, G.M. (2008) Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis. JACC: Cardiovascular Imaging, 1, 624-634. http://dx.doi.org/10.1016/j.jcmg.2008.06.003
|
[81]
|
Winter, P.M., Neubauer, A.M., Caruthers, S.D., Harris, T.D., Robertson, J.D., Williams, T.A., et al. (2006) Endothelial Alpha(v)Beta3 Integrin-Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2103-2109. http://dx.doi.org/10.1161/01.ATV.0000235724.11299.76
|
[82]
|
Hoffmann, R., Mintz, G.S., Dussaillant, G.R., Popma, J.J., Pichard, A.D., Satler, L.F., et al. (1996) Patterns and Mechanisms of In-Stent Restenosis. A Serial Intravascular Ultrasound Study. Circulation, 94, 1247-1254. http://dx.doi.org/10.1161/01.CIR.94.6.1247
|
[83]
|
Samaroo, H.D., Lu, J. and Webster, T.J. (2008) Enhanced Endothelial Cell Density on NiTi Surfaces with Sub-Micron to Nanometer Roughness. International Journal of Nanomedicine, 3, 75-82.
|
[84]
|
Kastrati, A., Mehilli, J., Pache, J., Kaiser, C., Valgimigli, M., Kelbaek, H., et al. (2007) Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. New England Journal of Medicine, 356, 1030-1039. http://dx.doi.org/10.1056/NEJMoa067484
|
[85]
|
Lagerqvist, B., James, S.K., Stenestrand, U., Lindbäck, J., Nilsson, T., Wallentin, L., et al. (2007) Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden. New England Journal of Medicine, 356, 1009-1019. http://dx.doi.org/10.1056/NEJMoa067722
|
[86]
|
Mauri, L., Hsieh, W.H., Massaro, J.M., Ho, K.K., D’Agostino, R. and Cutlip, D.E. (2007) Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. New England Journal of Medicine, 356, 1020-1029. http://dx.doi.org/10.1056/NEJMoa067731
|
[87]
|
Stone, G.W., Moses, J.W., Ellis, S.G., Schofer, J., Dawkins, K.D., Morice, M.C., et al. (2007) Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. New England Journal of Medicine, 356, 998-1008. http://dx.doi.org/10.1056/NEJMoa067193
|
[88]
|
Wieneke, H., Dirsch, O., Sawitowski, T., Gu, Y.L., Brauer, H., Dahmen, U., et al. (2003) Synergistic Effects of a Novel Nanoporous Stent Coating and Tacrolimus on Intima Proliferation in Rabbits. Catheterization and Cardiovascular Interventions, 60, 399-407. http://dx.doi.org/10.1002/ccd.10664
|
[89]
|
Bhargava, B., Reddy, N.K., Karthikeyan, G., Raju, R., Mishra, S., Singh, S., et al. (2006) A Novel Paclitaxel-Eluting Porous Carbon-Carbon Nanoparticle Coated, Nonpolymeric Cobalt-Chromium Stent: Evaluation in a Porcine Model. Catheterization and Cardiovascular Interventions, 67, 698-702. http://dx.doi.org/10.1002/ccd.20698
|
[90]
|
Ayon, A.A., Cantu, M., Chava, K., Agrawal, C.M., Feldman, M.D., Johnson, D., et al. (2006) Drug Loading of Nanoporous TiO2 Films. Biomedical Materials, 1, L11-L15. http://dx.doi.org/10.1088/1748-6041/1/4/L01
|
[91]
|
Liu, D.M., Yang, Q. and Troczynski, T. (2002) Sol-Gel Hydroxyapatite Coatings on Stainless Steel Substrates. Biomaterials, 23, 691-698. http://dx.doi.org/10.1016/S0142-9612(01)00157-0
|
[92]
|
Caves, J.M. and Chaikof, E.L. (2006) The Evolving Impact of Microfabrication and Nanotechnology on Stent Design. Journal of Vascular Surgery, 44, 1363-1368. http://dx.doi.org/10.1016/j.jvs.2006.08.046
|